Baxter ROA 2006-2018 | BAX

Current and historical return on assets (ROA) values for Baxter (BAX) over the last 10 years.
Baxter Annual ROA - Return on Assets
2017 4.23
2016 31.94
2015 1.88
2014 1.75
2013 1.25
2012 11.20
2011 11.83
2010 8.16
2009 12.76
2008 13.15
2007 11.25
2006 9.52
2005 7.53
Baxter Quarterly ROA - Return on Assets
Q2 2018 2.07
Q1 2018 2.30
Q4 2017 -0.36
Q3 2017 1.41
Q2 2017 1.56
Q1 2017 1.74
Q4 2016 1.54
Q3 2016 0.80
Q2 2016 7.58
Q1 2016 19.52
Q4 2015 0.91
Q3 2015 0.01
Q2 2015 0.25
Q1 2015 0.54
Q4 2014 0.49
Q3 2014 0.69
Q2 2014 1.83
Q1 2014 2.01
Q4 2013 1.62
Q3 2013 2.09
Q2 2013 2.48
Q1 2013 2.72
Q4 2012 2.21
Q3 2012 2.94
Q2 2012 3.58
Q1 2012 3.13
Q4 2011 2.48
Q3 2011 3.24
Q2 2011 3.55
Q1 2011 3.31
Q4 2010 2.44
Q3 2010 2.98
Q2 2010 3.26
Q1 2010 -0.35
Q4 2009 3.32
Q3 2009 3.14
Q2 2009 3.74
Q1 2009 3.46
Q4 2008 3.69
Q3 2008 3.13
Q2 2008 3.54
Q1 2008 2.89
Q4 2007 3.22
Q3 2007 2.79
Q2 2007 2.94
Q1 2007 2.78
Q4 2006 2.95
Q3 2006 2.69
Q2 2006 2.38
Q1 2006 2.21
Q4 2005 2.31
Q3 2005 0.84
Q2 2005 2.38
Q1 2005 1.62
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $37.778B $10.561B
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $122.654B 18.98
Abbott Laboratories (ABT) United States $111.276B 23.32
Stryker (SYK) United States $62.124B 24.00
Boston Scientific (BSX) United States $46.051B 23.96
Zimmer Biomet Holdings (ZBH) United States $24.917B 16.01
Smith & Nephew SNATS (SNN) United Kingdom $15.439B 0.00
ResMed (RMD) United States $15.234B 30.24
Bio-Rad Laboratories (BIO) United States $9.625B 61.86
Perrigo (PRGO) Ireland $9.529B 13.52
Hill-Rom Holdings (HRC) United States $6.247B 21.19
ICU Medical (ICUI) United States $6.000B 40.66
Canopy Growth (CGC) Canada $5.894B 0.00
Haemonetics (HAE) United States $5.175B 47.22
Insulet (PODD) United States $5.112B 0.00
Agios Pharmaceuticals (AGIO) United States $4.487B 0.00
Neogen (NEOG) United States $4.317B 68.78
Hutchison China MediTech (HCM) China $4.179B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.671B 0.00
NuVasive (NUVA) United States $3.382B 32.08
National Vision Holdings (EYE) United States $3.296B 0.00
Quidel (QDEL) United States $2.733B 56.00
Phibro Animal Health (PAHC) United States $2.018B 29.97
NxStage Medical (NXTM) United States $1.853B 0.00
Cardiovascular Systems (CSII) United States $1.239B 744.80
Eagle Pharmaceuticals (EGRX) United States $1.188B 35.07
AtriCure (ATRC) United States $1.089B 0.00
VAREX IMAGING (VREX) United States $1.086B 17.75
OraSure Technologies (OSUR) United States $1.015B 66.36
Orthofix (OFIX) United States $1.002B 30.51
TG Therapeutics (TGTX) United States $0.969B 0.00
Cerus (CERS) United States $0.958B 0.00
Surmodics (SRDX) United States $0.947B 114.43
Omeros (OMER) United States $0.931B 0.00
Owens & Minor (OMI) United States $0.930B 9.95
MacroGenics (MGNX) United States $0.870B 0.00
LeMaitre Vascular (LMAT) United States $0.705B 33.81
PetIQ (PETQ) United States $0.668B 0.00
Meridian Bioscience (VIVO) United States $0.632B 21.59
Insys Therapeutics (INSY) United States $0.555B 0.00
Evolus (EOLS) United States $0.534B 0.00
Lantheus Holdings (LNTH) United States $0.511B 15.89
NanoString Technologies (NSTG) United States $0.415B 0.00
Cytosorbents (CTSO) United States $0.359B 0.00
Utah Medical Products (UTMD) United States $0.341B 21.97
BioLife Solutions (BLFS) United States $0.338B 0.00
Quanterix (QTRX) United States $0.326B 0.00
Surface Oncology (SURF) United States $0.269B 0.00
Rockwell Medical (RMTI) United States $0.247B 0.00
Chimerix (CMRX) United States $0.206B 0.00
Fonar (FONR) United States $0.168B 10.19
Chembio Diagnostics (CEMI) United States $0.163B 0.00
Bovie Medical (BVX) United States $0.158B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.119B 0.00
Female Health (VERU) United States $0.110B 0.00
Trinity Biotech (TRIB) Ireland $0.090B 26.75
United-Guardian (UG) United States $0.086B 18.84
Oramed Pharmaceuticals (ORMP) Israel $0.085B 0.00
Neurotrope (NTRP) United States $0.077B 0.00
InfuSystems Holdings (INFU) United States $0.072B 0.00
CAS Medical Systems (CASM) United States $0.070B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.065B 0.00
Valeritas Holdings (VLRX) United States $0.036B 0.00
ImmuCell (ICCC) United States $0.036B 0.00
Capricor Therapeutics (CAPR) United States $0.031B 0.00
Akers Biosciences Inc (AKER) United States $0.025B 0.00
Myomo (MYO) United States $0.025B 0.00
Senestech (SNES) United States $0.018B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Cellectar Biosciences (CLRB) United States $0.008B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.003B 0.00